The EU’s vaccine rollout will continue picking up steam in coming months after a lacklustre performance in Q1. Supply constraints have now been largely resolved, thanks to boosted production capacity. Supply is now also well diversified and therefore less susceptible to disruptions. Additionally, improvements in logistics will see further increases in daily vaccination rates.
What you will learn from this report: